Why Lenz Therapeutics Stock Crashed Today

Lenz Therapeutics (NASDAQ: LENZ) stock tumbled 11.2% through 9:50 a.m. ET Tuesday after missing on Q4 earnings. Heading into the report, analysts forecast Lenz to lose $0.90 per share on quarterly sales of $3.1 million. Lenz lost $1.16 per share on sales of only $1.6 million. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: ...